Stay updated on Durvalumab + Tremelimumab in Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Durvalumab + Tremelimumab in Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab + Tremelimumab in Head and Neck Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Users now see a 403 Forbidden error on the study page, replacing the normal study record content and navigation. The page is currently inaccessible, preventing viewing details for this trial.
    Difference
    0.5%
    Check dated 2026-09-27T01:27:09.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the study content with an access-denied message. The header and footer remain visible.
    Difference
    17%
    Check dated 2026-09-20T00:26:35.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.5 to v3.6.6. This reflects a minor backend or content update to the ClinicalTrials.gov record.
    Difference
    0.0%
    Check dated 2026-08-29T20:15:00.000Z thumbnail image
  5. Check
    59 days ago
    Change Detected
    Summary
    Revision updated from v3.6.4 to v3.6.5, indicating a minor deployment update to the site. This change does not modify any study data or visible page content.
    Difference
    0.0%
    Check dated 2026-08-08T10:38:34.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.4, replacing the previous v3.6.3 revision. This appears to be a behind-the-scenes update to the page/template rather than a substantive change to study details.
    Difference
    0.0%
    Check dated 2026-07-25T05:17:32.000Z thumbnail image
  7. Check
    95 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.3, replacing the previous Revision: v3.6.2. This indicates a minor update to the page's version or template without altering study data.
    Difference
    0.0%
    Check dated 2026-07-03T21:46:04.000Z thumbnail image

Stay in the know with updates to Durvalumab + Tremelimumab in Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab + Tremelimumab in Head and Neck Cancer Clinical Trial page.